C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
11/2004
11/04/2004	US20040220202 antiinflammatory agents; central nervous system disorders; controlling cell proliferation, cell differentiation; anticancer agents; antidepressants
11/04/2004	US20040220196 antitumor agents; 4-amino-5-fluoro-3-(6-( 4-methylpiperazin-1-yl)1H-benzimidazol-2-yl)-quinolin-2-one
11/04/2004	US20040220193 Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound
11/04/2004	US20040220178 Substituted heterocycle fused gamma-carbolines
11/04/2004	US20040220174 for example, 1-(4-methoxyphenyl)-7-oxo-6-[5-(2-oxo-1-piperidinyl)2-pyridinyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide; use as anticoagulant agent for treatment of thromboembolic disorders
11/04/2004	US20040220173 central nervous system disorders; psychological disorders; Parkinson's disease; Huntington's disease ; sleep disorders
11/04/2004	US20040220172 Uracil substituted phenyl sulfamoyl carboxamides
11/04/2004	US20040220171 anticoagulants; immunomoderators; antiinflammatory agents
11/04/2004	US20040220169 anticoagulants; factor x inhibitor; N-[1-(5-chloro-1H-benzimidazol-2-yl)ethyl]-3-methyl-4-(2,5-dihydropyrrol-1-ylcarbonyl)benzamide
11/04/2004	US20040219446 Organophotoreceptors with azine-based compounds
11/04/2004	CA2523364A1 Cannabinoid receptor ligands and uses thereof
11/04/2004	CA2523205A1 Cannabinoid receptor ligands and uses thereof
11/04/2004	CA2523077A1 Imidazopyridine compounds having 5-ht4 receptor agonistic activity and 5-ht3 receptor antagonistic activity
11/04/2004	CA2522667A1 Combination of a cox-2 inhibitor and an alkylating-type antineoplastic agent for treatment of neoplasia
11/04/2004	CA2522562A1 2-phenyl-benzimidazol and 2-phenyl-imidazo-`4,5!-pyridine derivatives as checkpoint kinase cds1 (chk2) inhibitors for the treatment of cancer
11/04/2004	CA2522538A1 Pharmaceutically active ornithine derivatives, ammonium salts thereof and methods of making same
11/04/2004	CA2521538A1 Cannabinoid receptor ligands and uses thereof
11/04/2004	CA2520590A1 Substituted pyrroline kinase inhibitors
11/03/2004	EP1473599A1 Organophotoreceptors with azine-based compounds
11/03/2004	EP1473036A1 Zolpidem hemitartrate solvate
11/03/2004	EP1472255A1 Aza-arylpiperazines
11/03/2004	EP1472254A2 Purine and isosteric antibacterial compounds
11/03/2004	EP1472253A1 Sulphonyl compounds with 5 -ht6 receptor affinity
11/03/2004	EP1472252A1 Substituted fused pyrazolecarboxylic acid arylamides and related compounds
11/03/2004	EP1472245A2 Heteroaryl compounds useful as inhibitors of gsk-3
11/03/2004	EP1472223A1 Gamma secretase inhibitors
11/03/2004	EP1471913A2 Treatment of sleep disorders using sleep target modulators
11/03/2004	EP1471910A2 Substituted quinazolin-4-ylamine analogues as modulators of capsaicin receptors
11/03/2004	EP1395584A4 Uronium and immonium salts for peptide coupling
11/03/2004	EP1347974B1 Aminotriazolopyridiine derivatives as adenosine receptor ligands
11/03/2004	EP1339716B1 lactam-substituted pyrazolopyridine derivatives
11/03/2004	EP1313732B1 Oxindole derivatives
11/03/2004	EP1212103B1 4-fluoroalkyl-3-halophenyl nortropanes
11/03/2004	EP0942906B1 Compounds useful for inhibition of farnesyl protein transferase
11/03/2004	CN1543467A Diazacycloalkanes as oxytocin agonists
11/03/2004	CN1543465A Novel heterocyclic compounds as selective bacterial DHFR inhibitors and their uses thereof
11/03/2004	CN1543464A Novel imidazopyridine compounds with therapeutic effect
11/03/2004	CN1543452A 1,4-disubstituted benzenes as insecticides
11/03/2004	CN1542083A Emitting compound for organic electroluminescent device and organic electroluminescent device using the same
11/03/2004	CN1541532A Herbicidal synergistic composition, and method of controlling weeds
11/03/2004	CN1173975C Imidazopyridine derivatives
11/03/2004	CN1173951C Substituted 1,3-diaryl-2-pyridine-2-yl-3-(pyridine-2-ylamino)-propanol derivatives, methods for their production, pharmaceutical compositions containing the same and their use
11/02/2004	US6812349 Process and intermediates for the preparation of imidazopyridines
11/02/2004	US6812345 Fused pyridine-benzazapine, benzoxepin, or benzothiepin derivatives; hypocholesterolemic and hypolipidemic agents
11/02/2004	US6812243 Indole derivatives and their use for the treatment of malignant and other diseases based on pathological proliferation
11/02/2004	US6812237 (arylaminoaceamido)acetonitrile derivatives
11/02/2004	US6812234 Ccr-2; inflammatory, immunoregulatory, allergic, and autoimmune disorders and diseases
11/02/2004	CA2296313C 2-aminopyridines containing fused ring substituents as nos inhibitors
11/02/2004	CA2115536C Heterocyclically substituted phenyl-cyclohexane-carboxylic acid derivatives
10/2004
10/28/2004	WO2004092169A1 Spiropiperidine compound and medicinal use thereof
10/28/2004	WO2004092168A1 Cgrp receptor antagonists
10/28/2004	WO2004092167A1 Beta-carbolines useful for treating inflammatory disease
10/28/2004	WO2004092166A2 Cgrp receptor antagonists
10/28/2004	WO2004092162A1 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
10/28/2004	WO2004092143A1 A novel crystalline form of risperidone
10/28/2004	WO2004092135A2 Substituted benzosulphonamide as potentiators of glutamate receptors
10/28/2004	WO2004092134A1 [c]-fused bicyclic proline derivatives and their use for treating arthritic conditions
10/28/2004	WO2004092131A1 Indole derivatives as ppar modulators
10/28/2004	WO2004092116A1 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof
10/28/2004	WO2004091627A2 Heterocyclic substituted 1,4-dihydro-4-oxo-1,8-naphthpyridine analogs
10/28/2004	WO2004091625A1 (6-(phenoxy)-pyrido`3,4-d! pyrimidin-2-yl)-amine derivatives as p38 kinase inhibitors for the treatment of inflammatoryy conditions such as rheumatois artritis
10/28/2004	WO2004091619A1 A crystalline form iii of anhydrous moxifloxacin hydrochloride and a process for preparation thereof
10/28/2004	WO2004091542A2 Nitrogen containing integrin targeting compounds
10/28/2004	WO2004091518A2 Cxcr4 chemokine receptor binding compounds
10/28/2004	WO2004091504A2 Substituted quinobenzoxazine analogs
10/28/2004	WO2004091485A2 Aminoquinoline compounds
10/28/2004	WO2004032874A3 AZAINDOLE DERIVATIVES AS INHIBITORS OF p38 KINASE
10/28/2004	WO2004028539A3 1h-imidazo dimers
10/28/2004	WO2004010512A3 Heteroatom-containing diamondoid transistors
10/28/2004	WO2001039723A3 Triazospiro compounds having nociceptin receptor affinity
10/28/2004	US20040215015 Sulfonated derivatives of perylenetetracarboxylic acid dibenzimidazole sulfoderivatives anisotropic films for liquid crystals
10/28/2004	US20040215014 Auroyl cyclic amines for controlling behavior or appetite
10/28/2004	US20040214890 1,3-diamino-2-hydroxypropane derivatives are useful as inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mammal
10/28/2004	US20040214859 Zolpidem hemitartrate
10/28/2004	US20040214858 For use in short-term therapy of insomnia
10/28/2004	US20040214857 Substituted benzimidazoles and imidazo-[4,5]-pyridines
10/28/2004	US20040214856 Cannabinoid receptor ligands and uses thereof
10/28/2004	US20040214855 Cannabinoid receptor ligands and uses thereof
10/28/2004	US20040214853 Analgesics; side effect reduction; antidiabetic agents; central nervous system disorders
10/28/2004	US20040214852 Polysubstituted imidazopyridines
10/28/2004	US20040214850 Useful against multidrug resistant cancer cells
10/28/2004	US20040214838 such as 6-benzyl-3-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-2,6-dihydropyrazolo[3,4-c]pyridin-7-one; for treatment of eating disorders and psychological disorders
10/28/2004	US20040214837 such as 3-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-7-(4-methylpiperazin-1-yl)-2H-pyrazolo[4,3-d]pyrimidine; for treatment of eating disorders and psychological disorders
10/28/2004	US20040214834 Pyrazolo-pyridines for the treatment of herpes infections
10/28/2004	US20040214833 such as 3-methyl-9-methylamino-7-(pyridin-4-yl)-3H-imidazo[4,5-f]quinoline for use as analgesics
10/28/2004	US20040214832 Piperazine derivative renin inhibitors
10/28/2004	US20040214830 2,7-Substituted octahydro-1H-pyrido[1,2-a]pyrazine derivatives as ligands for serotonin receptors
10/28/2004	US20040214826 Method of treating sexual disturbances
10/28/2004	US20040214825 Method of treating sexual disturbances
10/28/2004	US20040214824 treating sexual disorders using (5R)-5-(methylamino)-5,6-dihydro-4H-imidazo[4,5,1-ij]quinoline-2(1H)-thione
10/28/2004	US20040214823 Administering a fused aminoquinoline derivative such as (5R)-5-(methylamino)-5,6-dihydro-4H-imidazo(4,5,1-ij) quinoline-2(1H)-thione
10/28/2004	US20040214817 Diaminotriazoles useful as inhibitors of protein kinases
10/28/2004	US20040214814 Pyrazole compounds useful as protein kinase inhibitors
10/28/2004	US20040214808 administering to treat thromboembolic disorders; cardiovascular disorders
10/28/2004	US20040214107 optical and electro-optical apparatus comprising recording layer consists of organic pigments and stabilizer agents, and reflection layers formed on light transmitting substrates; sensitivity for red light
10/28/2004	US20040214043 Acenaptho(1,2-k)fluoranthene derivatives; color purity, efficient light emission, durability
10/28/2004	DE10316659A1 Tricyclische Heteroaromatische Verbindungen Tricyclic heteroaromatic compounds
10/28/2004	CA2527170A1 Therapeutic compounds
10/28/2004	CA2521937A1 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof
10/28/2004	CA2521810A1 Substituted quinobenzoxazine analogs

1 ... 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 ... 646